【二磷酸氯奎/阿奇黴素抑制劑】SARS-CoV-2(COVID-19)新型冠狀病毒抗體/抗原/快篩開發
Chloroquine Diphosphate二磷酸氯奎 | CAS#50-63-5 貨號1825-100
An autophagy inhibitor
產品介紹: An antimalarial drug. Inhibits autophagy of glioma cells via a mechanism distinct from that of 3-Methyladenine. 抗瘧疾藥物氯奎,通過不同於3-甲基腺嘌呤(3-Methyladenine)的機制抑制神經膠質瘤細胞(glioma cells)的自噬(autophagy)。
Alternate Name | N⁴-(7-Chloro-4-quinolinyl)-N¹,N¹-dimethyl-1,4-pentanediamine diphosphate salt |
Appearance | White solid |
CAS # | 50-63-5 |
Molecular Formula | C₁₈H₂₆ClN₃·2H₃PO₄ |
Molecular Weight | 515.86 |
Purity | ≥98% by TLC |
Solubility | H₂O (100 mM) |
SMILES | CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl.OP(=O)(O)O.OP(=O)(O)O |
InChi | InChI=1S/C18H26ClN3.2H3O4P/c1-4-22(5-2)12-6-7-14(3)21-17-10-11-20-18-13-15(19)8-9-16(17)18;2*1-5(2,3)4/h8-11,13-14H,4-7,12H2,1-3H3,(H,20,21);2*(H3,1,2,3,4) |
InChi Key | QKICWELGRMTQCR-UHFFFAOYSA-N |
PubChem CID | 64927 |
MDL Number | MFCD00069852 |
Handling | Protect from air and moisture |
Storage Conditions | -20°C |
Shipping Conditions | RT |
Azithromycin | CAS#83905-01-5貨號B1226-100
A macrolide antibiotic
產品描述: 阿奇黴素 (Azithromycin) 是一種屬於大環內酯(macrolide antibiotic)的抗生素。阿奇黴素可抑制革蘭氏陽性(gram positive)和陰性細菌(negative bacteria)在轉肽(transpeptidation)步驟中50S核醣體亞基的形成和延長。與小鼠模型中的紅黴素(erythromycin)相比,體內活性顯示出改善的藥代動力學特性(pharmacokinetic properties)。
Alternate Name | 13-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-1-oxa-6-azacyclopentadecan-15-one |
Appearance | White solid |
CAS # | 83905-01-5 |
Molecular Formula | C₃₈H₇₂N₂O₁₂ |
Molecular Weight | 748.98 |
Purity | ≥98% by HPLC |
Solubility | DMSO (>50 mg/ml) |
SMILES | CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O |
InChi | CC[C@@H]1[C@@]([C@@H]([C@H](N(C[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O |
InChi Key | MQTOSJVFKKJCRP-BICOPXKESA-N |
PubChem CID | 447043 |
(-)-6-Azauridine 2’, 3’,5’-triacetate | 6-Azauridine | Acyclovir | Aphidicolin | Azidothymidine | Ritonavir
【2019-nCoV新型冠狀病毒】Spike S1 Protein、Spike RBD antigen、Human ACE2 Protein、Spike S1 antibody、2019-NCOV antibody
2019年新型冠狀病毒(2019 novel coronavirus , 2019-nCoV)導致人類感染及死亡,對人類健康構成了嚴重威脅。SARS-CoV特異性人類單克隆抗體CR3022可以與2019-nCoV RBD (6.3 nM的KD)有效結合。 CR3022的表位在2019-nCoV RBD中不與ACE2結合位點重疊。因此,CR3022有潛力被單獨或與其他中和抗體組合開發作為候選療法,用於預防和治療2019-nCoV感染。一些針對SARS-CoV ACE2結合位點的最有效的SARS-CoV特異性中和抗體(例如,m396,CR3014)未能結合2019-nCoV峰值蛋白,表明SARS-的RBD差異CoV和2019-nCoV對中和抗體的交叉反應具有至關重要的影響。文獻來源 Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody
Cat# | Name | Label | Expression system | |
Antigen | PNA001 | Spike S1 Protein | Fc | Expi293 |
PNA002 | Spike S1 Protein | His | Expi293 | |
PNA003 | Spike RBD antigen | Fc | Expi293 | |
PNA004 | Spike RBD antigen | His | Expi293 | |
PNA005 | Nucleocapsid Protein | His | E.coli | |
PHA001 | Human ACE2 Protein | Fc | Expi293 | |
PHA002 | Human ACE2 Protein | His | Expi293 | |
PMA001 | Mouse ACE2 Protein | Fc | Expi293 | |
PMA002 | Mouse ACE2 Protein | His | Expi293 | |
Antibody | AHA001 | Fully Human Spike RBD antibody(IgG) | / | ExpiCHO |
AHA003 | Fully Human Spike RBD antibody(IgG) | / | ExpiCHO | |
AHA004 | Fully Human Spike RBD antibody(IgG) | / | ExpiCHO | |
AHA005 | Fully Human Spike RBD antibody(IgM) | / | ExpiCHO | |
AHA006 | Nprotein antibody(IgG) | / | ExpiCHO | |
AHA007 | Human ACE2 antibody (IgG) | / | ExpiCHO | |
AHA008 | Spike S1 antibody | / | ExpiCHO | |
AHA009 | Nprotein antibody(IgG) | / | ExpiCHO | |
AHA010 | Nprotein antibody(IgG) | / | ExpiCHO | |
AHA011 | Nprotein antibody(IgG) | / | ExpiCHO | |
AHA012 | Human ACE2 antibody (IgG) | / | ExpiCHO | |
ANA001 | Spike RBD nano antibody | / | ExpiCHO | |
ANA002 | Spike RBD nano antibody | / | ExpiCHO | |
ANA003 | Spike RBD nano antibody | / | ExpiCHO | |
ANA004 | Spike RBD nano antibody | / | ExpiCHO | |
CHA001 | SARS antibody-80R (IgG) | / | ExpiCHO | |
CHA002 | MERS antibody-2E6 (IgG) | / | ExpiCHO | |
CHA003 | MERS antibody-3A1 (IgG) | / | ExpiCHO | |
CHA004 | MERS antibody-D12 (IgG) | / | ExpiCHO | |
CHA005 | 2019-NCOV antibody-CR3022 (IgG) | / | ExpiCHO |
40nm奈米金抗體標誌套組 (20 O.D) | Expedeon 貨號 230-0010
產品規格: 粒徑大小40nm | 奈米金濃度: 20 OD | 10個小反應 ( 10 mini kit) InnovaCoat® GOLD – 20OD 40nm Gold Conjugation Kits
產品敍述: InnovaCoat® GOLD奈米金外層進行專利包覆;其抗體結合效能近乎100%,且不須考量等電點及pH之問題。市面上多數奈米金抗體標誌產品,受限於等電點及pH等問題。在lateral flow test開發過程中,奈米金標誌效能都不高,而且還會有失效的問題。Innova Biosciences 專利研發奈米金標誌 InnovaCoat GOLD,100%結合效率;讓lateral flow test快篩試驗的應用,更具最佳化。建立良好的奈米金標幟抗體,其靈敏度遠高於ELISA方法。
產品特點: InnovaCoat奈米金抗體標幟,其訊號高於傳統奈米金標誌。辨視NH3端官能基,可標誌抗體、蛋白質、胜肽等具NH3端官能基之結合位置;結合方式以共價鍵鍵結,性質極為穩定。傳統市售奈米金標幟其O.D為0.5,InnovaCoat的光密度為O.D=20。抗體選擇上,不須考量等電點及pH問題,抗體標幟效能近乎100%,可大幅節省抗體用量(每次反應僅需要0.4μg~0.17μg抗體量)。
抗體純化相關商品 TCS抗體純化系統 (Mouse IgG ) | BSA Removal kit | 抗體純化 (腹水/免疫血清 ) | 抗體濃縮和Clean-up試劑盒 | AbPure™小鼠抗體純化
型號 | 產品名稱 |
奈米金大小 |
包裝 |
InnovaCoat® GOLD 10-80nm奈米金-利用Amine連結 | |||
228-0005 228-0010 228-0015 |
InnovaCoat® GOLD – 20OD 10nm Gold Particle Kits | 10nm | 3 × Mini Kit 10 × Mini Kit 1 × Midi Kit |
229-0005 229-0010 229-0015 |
InnovaCoat® GOLD – 20OD 20nm Gold Particle Kits | 20nm | 3 × Mini Kit 10 × Mini Kit 1 × Midi Kit |
230-0005 230-0010 230-0015 |
InnovaCoat® GOLD – 20OD 40nm Gold Particle Kits | 40nm | 3 × Mini Kit 10 × Mini Kit 1 × Midi Kit |
232-0005 232-0010 232-0015 |
InnovaCoat® GOLD – 20OD 60nm Gold Particle Kits | 60nm | 3 × Mini Kit 10 × Mini Kit 1 × Midi Kit |
231-0005 231-0010 231-0015 |
InnovaCoat® GOLD – 20OD 80nm Gold Particle Kits | 80nm | 3 × Mini Kit 10 × Mini Kit 1 × Midi Kit |
提供抗體-奈米金結合方向性 |
|||
270-0005 270-0015 |
InnovaCoat® GOLD – Maleimide 20OD Orientated labeling of Fab’ (sulfhydryl groups) |
40nm | 3 × Mini Kit 1 × Midi Kit |
280-0100 280-0000 280-0300 |
InnovaCoat® GOLD – Hydrazide Site-specific labeling of Fc – IgG (aldehydes) |
40nm | 1 × Mini Kit 3 × Mini Kit 1 × Midi Kit |
其他產品 |
|||
240-0200 240-1000 |
InnovaCoat® GOLD Biotin | 40nm | 200μl pack 1ml pack |
250-0200 250-1000 |
InnovaCoat® GOLD Streptavidin | 40nm | 200μl pack 1ml pack |
奈米金介紹
奈米金(又稱為膠體金),常以溶液型態呈現。當奈米金粒子越小(<100nm)則呈現紅色溶液。反之(>100nm)則越偏向藍紫色。奈米金粒子用途廣泛,可應用於橫向流分析、顯微影像、流式細胞、萊曼光譜、以及動態光散射(DLS)。在這些應用中,奈米金粒子的大小是非常重要的影響關鍵。雖然奈米金的來源多種(自製or商品化產品),InnovaGOLD奈米金經過嚴格的測試而得以生成優良產品。
相關商品 Streptavidin-gold奈米金粒子(40nm) | Streptavidin-gold奈米金粒子(20nm) | Biotin-gold奈米金粒子(40nm) | 10-80nm奈米金抗體標誌套組 | 奈米金溶液